II. Epidemiology
-
Prevalence in Children
- Obstructive Sleep Apnea: 1-5%
- Snoring: 3-12%
- Isolated loud snoring without apnea in up to 27% of children
- Onset: Ages 2-8 years old
- Gender predominance
III. Types
- Obstructive Sleep Apnea (OSA)
-
Upper Airway Resistance Syndrome (UARS)
- Disordered breathing despite normal Polysomnogram
IV. Risk Factors
- Black ethnicity
- Obesity
- Pectus Excavatum
- Tobacco Smoke Exposure
- Pediatric Neuromuscular Disorder
- Craniofacial abnormalities
- Craniosynostosis (e.g. Apert's Syndrome)
- Micrognathia (e.g. Pierre Robin Syndrome)
- Retrognathia
- Midfacial hypoplasia
- Trisomy 21 (Down Syndrome)
- Macroglossia
- Choanal Atresia
V. Causes
- Large Tonsils, adenoids (Adenotonsillar Hypertrophy)
- Nasoseptal obstruction
- Allergic Rhinitis
VI. Symptoms
- Altered observed sleep-related breathing patterns
- Snoring
- Mouth breathing
- Frequent Nocturnal awakenings
- Witnessed apneas, Choking or paradoxical breathing
- Behavior changes
- Daytime Sleepiness (less common, but seen in obese children)
- Nocturnal Enuresis
- Decreased attention
- Unusual behavior
- Poor academic performance
- Atypical sleep position
- Hyperextended neck
- Seated with mouth open
- Associated symptoms
- Morning Headache
- Night Sweats
VII. Signs
- Assess growth
- Obtain height and weight and plot for Growth Velocity
- Assess for Failure to Thrive
- Calculate Body Mass Index for Pediatric Obesity
-
Adenotonsillar Hypertrophy
- See Tonsillar Hypertrophy Grading Scale
- See Mallampati Score
- Tonsillar grading does not correlate with Obstructive Sleep Apnea severity
- Craniofacial abnormalities
- Adenoid Facies (long face syndrome)
- Long face with open mouth
- Seen in children with adenoid hypertrophy
- High Arched Palate
- Macroglossia
- Micrognathia
- Midfacial hypoplasia
- Adenoid Facies (long face syndrome)
- Nasal obstruction
- Choanal Atresia or septal deviation in infants
- Turbinate swelling or Nasal Polyps in children
- Chest abnormalities (e.g. Pectus Excavatum)
- Neurologic Exam
VIII. Imaging
- Lateral neck XRay (consider)
IX. Associated Conditions
X. Complications
- Failure to Thrive
- Pulmonary Hypertension
- Systemic Hypertension
- Attention Deficit Disorder-like behavior (or other worsening school performance)
XI. Diagnosis
-
Adenotonsillar Hypertrophy with OSA symptoms
- See Tonsillar Hypertrophy Grading Scale
- No further studies needed to indicate Tonsillectomy
- Polysomonogram
- Indications (required in most cases of suspected pediatric OSA)
- Craniofacial abnormalities
- Comorbid conditions
- Unclear diagnosis
- Precautions
- Polysomnogram may be normal despite UARS (above)
- Home Sleep Apnea testing and abbreviated Polysomnograms are not recommended in children
- Criteria for Obstructive Sleep Apnea Diagnosis
- Pediatric criteria differs from that for adults
- Apnea-Hypopnea Index >1.5 events per hour of sleep
- Minimum Oxygen Saturation <92%
- Indications (required in most cases of suspected pediatric OSA)
XII. Management
-
Adenotonsillar Hypertrophy
- Adenotonsillectomy is treatment of choice in almost all cases of pediatric Obstructive Sleep Apnea
- Efficacy: Resolution of Obstructive Sleep Apnea after Adenotonsillectomy
- Non-Obese: 70%
- Obese: 30%
- Indications for hospital observation overnight stay after Adenotonsillectomy (risk of post-op respiratory compromise)
- Age <3 years
- Pediatric Neuromuscular Disorders
- Chromosomal Abnormalities
- Loud snoring with apnea prior to surgery
- Post-operative management
- Repeat Polysomnogram in 6-8 weeks after Adenotonsillectomy to evaluate for Sleep Apnea resolution
- Consider sleep medicine referral for high risk cases or those who fail resolution after Adenotonsillectomy
- References
- Management if Tonsillectomy not effective or contraindicated
- Manage Obesity in Children
- Continuous positive airway pressure (CPAP)
- See CPAP for Obstructive Sleep Apnea
- Recheck mask fitting every 6 months
- Treat concurrent Allergic Rhinitis
- Nasal Corticosteroids
- Consider Montelukast (Singulair)
- Treat recurrent Tonsillitis
- Consider course of Antibiotics
- Rapid Maxillary expansion
- Orthodontic device to widen the upper jaw
- Uvulopalatopharyngoplasty (UPPP) Indications
- No longer recommended due to low efficacy in adults
- Oropharyngeal soft tissue obstruction
- See Mallampati Score
- Severe OSA without Adenotonsillar Hypertrophy
- Trisomy 21
- Indications for sleep medicine referral: higher risk conditions
- Cardiorespiratory failure
- Craniofacial abnormalities or congenital defects
- Attention Deficit Disorder
- Management of severe OSA refractory to above measures
- Tracheotomy